Accelerated-phase CML is characterized by faster progression than chronic phase, with variable symptom burden including fatigue, weight loss, night sweats, bruising, and splenic enlargement.
Chronic myeloid leukemia (CML) represents a clonal malignancy arising from hematopoietic stem cells, constituting roughly 15% of newly identified cases of leukemia in the adult population 1. The ...
Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology ...
BCR-ABL1, derived from structural chromosome rearrangements, is the driver mutation in chronic myeloid leukemia (CML). Targeting BCR-ABL1 for degradation is an ideal therapeutic strategy for CML, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results